Athenex, Inc. (48) | Purchase Agreements (2)
- Purchase Agreement, by and between Athenex, Inc. and ImmunityBio, Inc. dated January 7, 2022 (Filed With SEC on January 12, 2022)
- Asset Purchase and Sale Agreement dated as of September 1, 2020 by and between Athenex Pharmaceutical Division, LLC and Ingenus Pharmaceuticals, LLC (Filed With SEC on March 1, 2021)
